» Articles » PMID: 32029944

Metastatic Basal Cell Carcinoma: Case Report and Review of the Literature

Overview
Specialty Dermatology
Date 2020 Feb 8
PMID 32029944
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Basal cell carcinoma (BCC) is the most commonly occurring carcinoma among humans. However, despite their overall frequency, cases of BCC featuring metastases are extremely rare. We present the case of a male patient with BCC located in the chest, measuring 10 cm and with an evolution of 15 years. After several years, an axillary recurrence developed as a tumor mass affecting the lymph nodes. After 14 months, a further lymph node recurrence was observed and resected. Six months later, a pulmonary nodule was detected, which was resected with tumor-free margins. Histopathological report revealed infiltration by BCC. After 13 years of follow-up (after the removal of the primary tumor), the patient remained alive and received close clinicoradiological monitoring. Taking advantage of this opportunity, we also provide a brief review of the corresponding literature.

Citing Articles

Deep Convolutional Neural Support Vector Machines for the Classification of Basal Cell Carcinoma Hyperspectral Signatures.

Courtenay L, Gonzalez-Aguilera D, Laguela S, Del Pozo S, Ruiz C, Barbero-Garcia I J Clin Med. 2022; 11(9).

PMID: 35566440 PMC: 9102335. DOI: 10.3390/jcm11092315.

References
1.
Ganti A, Kessinger A . Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer. Cancer Treat Rev. 2011; 37(6):440-3. DOI: 10.1016/j.ctrv.2010.12.002. View

2.
Lattes R, Kessler R . Metastasizing basal-cell epithelioma of the skin; report of two cases. Cancer. 1951; 4(4):866-78. DOI: 10.1002/1097-0142(195107)4:4<866::aid-cncr2820040424>3.0.co;2-f. View

3.
Axelson M, Liu K, Jiang X, He K, Wang J, Zhao H . U.S. Food and Drug Administration approval: vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma. Clin Cancer Res. 2013; 19(9):2289-93. DOI: 10.1158/1078-0432.CCR-12-1956. View

4.
Danial C, Lingala B, Balise R, Oro A, Reddy S, Colevas A . Markedly improved overall survival in 10 consecutive patients with metastatic basal cell carcinoma. Br J Dermatol. 2013; 169(3):673-6. PMC: 4006071. DOI: 10.1111/bjd.12333. View

5.
Ruiz Salas V, Alegre M, Garces J, Puig L . Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies. Expert Rev Anticancer Ther. 2014; 14(6):741-9. DOI: 10.1586/14737140.2014.895326. View